Virtual reality isn’t quite there yet as a go-to screening tool for cognitive decline, but it can augment conventional methods. And senior citizens are open to its use for that purpose when it’s administered by their primary care doctor.
If geriatricians and primary care doctors could know which of their aging patients are at risk for Alzheimer’s disease, they could help these patients and their families prepare for what’s to come.
Researchers at the University of Delaware are developing a system of wearable video devices and AI analysis tools that, they hope, will help make roads and sidewalks friendlier to walkers, joggers, bicyclists and anyone else keeping fit outdoors.
AI in healthcare has long been touted as an innovative technology that will accelerate care treatments and even replace some tasks performed by clinicians. But its impact might be inequitable in the future.
Cerner, a global health platform, has teamed up with Amazon Web Services, a subsidiary of Amazon that offer cloud computing platforms, to accelerate healthcare solutions and AI in healthcare.
Allowing natural language processing to pore over disparate data stored in electronic health records, researchers in Canada have shown the AI-based technology can reveal real-world experiences and outcomes of patients with stage III breast cancer.
An AI company owned by Google parent company Alphabet, DeepMind, is able to predict future acute kidney injuries and could potentially save lives, according to a new paper published in Nature.
The drug industry is not happy about a new plan from the Trump administration that would allow cheaper drugs to be imported from Canada. The initiative, called the Safe Importation Action Plan, was announced by HHS July 31.
NIH funding opportunities remain numerous for innovators who apply evidence-based medical science to their proposals for smartphone apps, and the agency isn’t hesitant to get behind AI-based approaches.
Average Medicare Part D premiums have dropped for the third year in a row, according to CMS, and they are projected to decline again in 2020. Medicare Part D plans offer prescription drug coverage to Medicare beneficiaries.
